4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-25-000003
Director acquired 3,074 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Kenneth Carl Director | 2025-01-02 | Grant or award | +3,074 | $3.66 | $11,251 | 119,768 | D |
Loading xslF345X05/wk-form4_1735938496.xml…